COPD Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with COPD (chronic obstructive pulmonary disease) by a lung specialist, confirmed using 2025 GOLD guidelines.
• People whose lung function test results show that the airways are not severely restricted (FEV1 at or above 30% of the expected value for their age and size).
• People whose breathing test results show a specific pattern of airflow limitation after using a bronchodilator (a medicine that opens the airways), based on a ratio called FEV1/FVC being below 0.7.
• People whose breathing does not significantly improve after using a bronchodilator during testing (negative reversibility test).
• People who are willing to give written consent to take part in the study.

Who may not be able to join:

• People currently experiencing a COPD flare-up (worsening of symptoms).
• People who currently have cancer or have had cancer in the past five years.
• People who have a muscle or bone condition that prevents them from moving independently or taking part in exercise tests and training.
• People who have had surgery or a significant injury to the chest, stomach, skull, brain, or eye area within the past six months.
• People who have been diagnosed with severe heart valve disease.
• People who have an implanted heart device called a cardioverter-defibrillator.
• People who have a diagnosed irregular heartbeat that carries a risk of losing consciousness.
• People with an acute (sudden or active) coronary artery condition affecting the heart.
• People who have epilepsy.
• People who have high blood pressure that is not controlled even with medication.
• People who have a condition that weakens the immune system, whether present from birth or developed later.
• People who need oxygen therapy (either ongoing or intermittent) due to breathing failure.
• People who have had an infectious illness with fever either during the study or within the two weeks before it begins.
• People who have claustrophobia (fear of enclosed spaces).
• People who are pregnant.
• People who are currently taking part in another rehabilitation program at the same time.
• People whose medication treatment changes significantly during the course of the study.

Important: Always verify eligibility with the trial site directly before applying.